- Home
- GRC vs RXRX Comparison
GRC vs RXRX Comparison
Compare GRC & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRC | RXRX |
|---|---|---|
| Founded | 1933 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRC | RXRX |
|---|---|---|
| Price | $78.44 | $3.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 212.3K | ★ 22.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 32.03 | 14.79 |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $682,389,000.00 | $74,681,000.00 |
| Revenue This Year | $6.62 | $12.11 |
| Revenue Next Year | $4.66 | $82.52 |
| P/E Ratio | $116.91 | ★ N/A |
| Revenue Growth | 3.44 | ★ 26.92 |
| 52 Week Low | $36.41 | $2.77 |
| 52 Week High | $92.78 | $7.18 |
Technical Indicators
Market Signals| Indicator | GRC | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 44.27 |
| Support Level | $45.19 | $2.88 |
| Resistance Level | $79.02 | $4.03 |
| Average True Range (ATR) | 3.24 | 0.26 |
| MACD | -1.55 | -0.01 |
| Stochastic Oscillator | 11.05 | 21.00 |
Price Performance
Historical ComparisonAbout GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.